medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2013, Número 4

<< Anterior Siguiente >>

Dermatología Cosmética, Médica y Quirúrgica 2013; 11 (4)


Patología dermatológica genital

Peña RAG, Díaz GJM, Domínguez CJ, Domínguez SL

Idioma: Español
Referencias bibliográficas: 70
Paginas: 288-302
Archivo PDF: 405.89 Kb.


RESUMEN

Los genitales pueden presentar una gran variedad de dermatosis originadas en la región o secundarias a trastornos sistémicos. Estas entidades son relativamente comunes en la consulta dermatológica, por lo que es indispensable conocer el cuadro clínico, su abordaje, diagnóstico y tratamiento. Ésta es una revisión de la patología dermatológica genital más frecuente e incluye un análisis somero sobre etiología, diagnóstico y tratamiento de cada entidad.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Agrawal SK, Bhattacharya SN, Singh N. “Pearly penile papules: a review”. Int J Dermatol 2004: 43; 199-201.

  2. Hogewoning CJ, Bleeker MC, van den Brule AJ, et al. “Pearly penile papules: Still no reason for uneasiness”. J Am Acad Dermatol 2003; 49: 50-54.

  3. Chih-Chieh C., Hsien-Ching C. “Vestibular Papillomatosis”. N Engl J Med 2008; 358: 1495.

  4. Alikhan A, Felsten LM, Daly M, et al. “Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up”. J Am Acad Dermatol 2011; 65: 473-491.

  5. Zhang Z, Xu SX, Zhang FY, Yin XY, Yang S, Xiao FL, et al. “The analysis of genetics and associated autoimmune diseases in Chinese vitiligo patients”. Arch Dermatol Res 2009; 301: 167-173.

  6. Bolognia JL , Jorizzo JL, Schaffer JV. Dermatology. 3a ed, EUA, Elsevier, 2012.

  7. Taieb A, Alomar A, Bohm M, et al. “Guidelines for the management of vitiligo: the European Dermatology Forum consensus”. Br J Dermatol 2013; 168: 5-19.

  8. Christophers E: “Psoriasis-epidemiology and clinical spectrum”. Clin Exp Dermatol 2001; 26: 314-320.

  9. Swanbeck G, Inerot A, Martinsson T, et al. “Age at onset and different types of psoriasis”. Br J Dermatol 1995; 133: 768-773.

  10. Schmitt-Egenolf M, Eiermann TH, Boehncke WH, et al. “Familial juvenile onset psoriasis is associated with the human leukocyte antigen (HLA) class I side of the extended haplotype Cw6-B57-DRB1*0701- DQA1*0201-DQB1*0303: a population- and family-based study”. J Invest Dermatol 1996; 106: 711-714.

  11. Meeuwis KA, de Hullu JA, van de Nieuwenhof HP, et al. “Quality of life and sexual health in patients with genital psoriasis”. Br J Dermatol. 2011; 164: 1247-1255.

  12. Quan MB, Ruben BS. “Pustular psoriasis limited to the penis”. Int J Dermatol 1996; 35: 202-204.

  13. van Dijk F, Thio HB, Neumann HAM. “Non-Oncological and Non- Infectious Diseases of the Penis (Penile Lesions)”. EAU–EBU Upt. 2006; 4: 13-19.

  14. Menter CA, Korman NJ, Elmets CA, “Guidelines of care for the management of psoriasis and psoriatic arthritis”. J Am Acad Dermatol 2011; 65: 137-174.

  15. Meeuwis K, Hullu J, Massuger L, Keerkhof P, Rossum M. “Genital psoriasis: a systematic literature review on this hidden skin disease”. Acta Derm Venereol. 2011; 91: 5-11.

  16. F. van Dijk, Neumann T. “Non-Oncological and Non-Infectious Diseases of the Penis (Penile Lesions)”. EAU-EBU update series 4 (2006): 13-19.

  17. Hoshi A, Usui Y, Terachi T. “Penile Carcinoma Originating From Lichen Planus on Glans Penis”. Urology 2008 May; 71(5): 816-817.

  18. Petropoulou H. “Effective treatment of erosive lichen planus with thalidomide and topical tacrolimus”. Int J Dermatol. 2006 Oct; 45(10): 1244-1245.

  19. Porter WM, Dinneenà M, Hawkins DA, Bunker CB. “Erosive penile lichen planus responding to circumcision”. J Eur Acad Dermatol Venereol 2001 May; 15(3): 266-268.

  20. Lewis FM. “Vulval lichen planus”. Br J Dermatol 1998; 138: 569-575.

  21. Clouston D, Hall A, Lawrentschuk N. “Penile lichen sclerosus (balanitis xeroticaobliterans)”. BJUI 2011; 108(Supp 2): 14-19.

  22. Lukowsky A, Muche JM, Sterry W, et al. “Detection of expanded T cell clones in skin biopsy samples of patients with lichen sclerosus et atrophicus by T cell receptor-gamma polymerase chain reaction assays”. J Invest Dermatol 2000; 115: 254-259.

  23. Meyrick Thomas RH, Ridley CM, McGibbon DH, et al. “Lichen sclerosus et atrophicus and autoimmunityea study of 350 women”. Br J Dermatol 1988; 118: 41-46.

  24. Harrington CI, Dunsmore IR. “An investigation into the incidence of auto-immune disorders in patients with lichen sclerosus and atrophicus”. Br J Dermatol 1981; 104: 563-566.

  25. Bunker CB. “Topics in penile dermatology”. Clin Exp Dermatol 2001; 26: 469-479.

  26. Ching-Chi Chi, Kirtschig G, Baldo M, et al. “Systematic review and metaanalysis of randomized controlled trials on topical interventions for genital lichen sclerosus”. J Am Acad Dermatol 2012; 67: 305-312.

  27. Edmonds EVJ, Hunt S, Hawkins D, et al. “Clinical parameters in male genital lichen sclerosus: a case series of 329 patients”. JEADV 2012; 26: 730-737.

  28. Fistarol S, Itin P. “Diagnosis and Treatment of Lichen Sclerosus An Update”. Am J Clin Dermatol (2013); 14: 27-47.

  29. Yoganathan S, Bohl TG, Mason G. “Plasma cell balanitis and vulvitis (of Zoon). A study of 10 cases”. J Reprod Med 1994; 39: 939-944.

  30. Bunker CB. “Topics in penile dermatology”. Clin Exp Dermatol. 2001; 26: 469-479.

  31. English JC, MC, Laws RA, Keough GC, Wilde JL, Foley JP, Elston DM. “Dermatoses of the glans penis and prepuce”. J Am Acad Dermatol 1997; 37: 1-24.

  32. Sonnex C. “Genital allergy”. Sex Transm Infect 2004; 80:4-7.

  33. Plaza JA, James WD. “Erythema Multiforme”. http://emedicine.medscape. com/article/1122915-overview.

  34. Guerra Tapia A. “Patologia Genital Masculina ampollosa no venérea”. Monografías de Dermatología 2012; 25: 103-109.

  35. Sekula P, Dunant A, Mockenhaupt M, Naldi L, Bouwes Bavinck JN, Halevy S, Kardaun S, Sidoroff A, Liss Y, Schumacher M, Roujeau JC. “Comprehensive Survival Analysis of a Cohort of Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis”. J Invest Dermatol 2013 Feb 7 [doi: 10.1038/jid.2012.510. Epub ahead of print].

  36. Shriner D, Schwartz R, Janniger C. “Impetigo”. Cutis 1994; 45: 30-32.

  37. Stevens DL, Bisno AL, Chambers HF, et al. “Practice guidelines for the diagnosis and management of skin and soft-tissue infections”. Clin Infect Dis 2005; 41: 1373.

  38. Edwards SK, “European Branch of the International Union against Sexually Transmitted Infection and the European Office of the World Health Organization. European guideline for the management of balanoposthitis”. Int J Std AIDS 2001; 12 (Suppl 3): 68.

  39. Stary A, Soeltz-Szoets J, Ziegler C, et al. “Comparison of the efficacy and safety of oral fluconazole and topical clotrimazole in patients with candida balanitis”. Genitourin Med 1996; 72: 98.

  40. Pappas PG, Kauffman CA, Andes D, et al. “Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America”. Clin Infect Dis 2009; 48: 503.

  41. Ross JD, Smith IW, Elton RA. “The epidemiology of herpes simplex types 1 and 2 infection of the genital tract in Edinburgh 1978-1991”. Genitourin Med 1993; 69: 381.

  42. Kimberlin DW, Rouse DJ. “Clinical practice. Genital herpes”. N Engl J Med 2004; 350: 1970.

  43. Benedetti JK, Zeh J, Corey L. “Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time”. Ann Intern Med 1999; 131: 14.

  44. Gupta R, Warren T, Wald A. “Genital herpes”. Lancet 2007; 370: 2127.

  45. Schomogyi M, Wald A, Corey L. “Herpes simplex virus-2 infection. An emerging disease?” Infect Dis Clin North Am 1998; 12: 47.

  46. Corey L, Fife KH, Benedetti JK, et al. “Intravenous acyclovir for the treatment of primary genital herpes”. Ann Intern Med 1983; 98: 914.

  47. http://www.cdc.gov/std/treatment/2010/default.htm Mattison HR, Reichman RC, Benedetti J, et al. “Double-blind, placebocontrolled trial comparing long-term suppressive with short-term oral acyclovir therapy for management of recurrent genital herpes”. Am J Med 1988; 85:20.

  48. Cernik C, Gallina K, Brodell RT. “The treatment of herpes simplex infections: an evidence-based review”. Arch Intern Med 2008; 168: 1137.

  49. Corey L, Bodsworth N, Mindel A, et al. “An update on short-course episodic and prevention therapies for herpes genitalis”. Herpes 2007; 14 (Suppl 1): 5A.

  50. Dworkin RH, Johnson RW, Breuer J, et al. “Recommendations for the management of herpes zoster”. Clin Infect Dis 2007; 44(Suppl 1): S1.

  51. Rowbotham M, Harden N, Stacey B, et al. “Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial”. JAMA 1998; 280: 1837.

  52. Chen N, Ynag M, He L. “Corticosteroids for preventing postherpetic neuralgia”. Cochrane Database Syst Rev 2010 Dec; 8(12): CD005582.

  53. Gormley RH, Kovarik CL. “Human papillomavirus-related genital disease in the immunocompromised host (part I and II)”. J Am Acad Dermatol 2012; 66: 883.

  54. Von Krogh G, Lacey CJN, Gross G, et al. “European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts”. Sex Transm Infect 2000; 76: 162-168.

  55. Kwok CS, Holland R, Gibbs S. “Efficacy of topical treatments for cutaneous warts: a meta-analysis and pooled analysis of randomized controlled trials”. Br J Dermatol 2011; 165: 233-246.

  56. Hook EW 3rd, Marra CM. “Acquired syphilis in adults”. N Engl J Med 1992; 326:1060.

  57. Wong W, Chaw JK, Kent CK, Klausner JD. “Risk factors for early syphilis among gay and bisexual men seen in an STD clinic: San Francisco, 2002-2003”. Sex Transm Dis 2005; 32: 458.

  58. Blain AK, Elston DM. “Seborreic Keratosis”. http://emedicine.medscape. com/article/1059477-workup#a0722.

  59. Gill D, Dorevitch A, Marks R. “The prevalence of seborrheic keratoses in people aged 15 to 30 years: is the term senile keratosis redundant?” Arch Dermatol. Jun 2000; 136(6): 759-762.

  60. Provost N, Kopf AW, Rabinovitz HS, Oliviero MC, Toussaint S, Kamino HH. “Globulelike dermoscopic structures in pigmented seborrheic keratosis”. Arch Dermatol. Apr 1997; 133(4): 540-541.

  61. Schwartz RA, Elston DM. “Acrochordon”. http://emedicine.medscape.com/

  62. Lynch PJ. “Lichen simplex chronicus (atopic/neurodermatitis) of the anogenital región”. Dermatol Ther. 2004; 17(1): 8-19.

  63. Wikström A, Hedblad MA, Syrjän S. “Penile intraepithelial neoplasia: histopathological evaluation, HPV typing, clinical presentation and treatment”. JEADV 2012; 26: 325-330.

  64. Chaux A, Cubilla AL. “Advances in the pathology of penile carcinomas”. Human Pathology 2012; 43(6): 771-789.

  65. Chaux A, Velazquez EF, Barreto JE, Ayala E, Cubilla AL. “New pathologic entities in penile carcinomas: an update of the 2004 world health organization classification”. Semin Diagn Pathol. 2012 May; 29(2): 59-66.

  66. Rodríguez Pichardo A, “Lesiones precancerosas del pene y misceláneas”. Monografías de Dermatología, Patología genital masculina, no venérea. 2012; 25(2): 122-129.

  67. Seetharamu N, Ott PA, Pavlick AC. “Mucosal Melanomas: A Case- Based Review of the Literature”. Oncologist. 2010 July; 15(7): 772-781.

  68. Tran Janco JM, Markovic SN, Weaver AL, Cliby AW. “Vulvar and vaginal melanoma: Case series and review of current management options including neoadjuvant chemotherapy”. Gynecol Oncol. 2013; Feb 26 (en impresión).

  69. Sánchez R, Huang SF, Tamboli P, Prieto VG, Hester G, Pettaway A. “Melanoma of the penis, scrotum and male urethra: a 40-year single institution experience”. J Urol. 2005 Jun; 173(6): 1958.

  70. Bichakjian CK, Halpern AC, Johnson TM, Hood AF, Grichnik JM, Swetter SM, et al. “Guidelines of care for the management of primary cutaneous melanoma”. J Am Acad Dermatol 2011; 65: 1032-1047.




2020     |     www.medigraphic.com